$1.15
-0.06-4.96%
At Close: -
$1.15
00.00%
After Hours: Sep 20, 4:16 PM EDT
15 minutes delayed
Aclaris Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Aclaris Therapeutics using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-07 | $-0.15 | $-0.20 | 25.0 % |
Mar 2024 | 2024-05-07 | $-0.24 | $-0.29 | 17.2 % |
Dec 2023 | 2024-02-27 | $-0.30 | $-0.34 | 11.8 % |
Sep 2023 | 2023-11-06 | $-0.41 | $-0.48 | 14.6 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-07 | $2.77M | $1.82M | 52.0 % |
Mar 2024 | 2024-05-07 | $2.40M | $1.37M | 75.0 % |
Dec 2023 | 2024-02-27 | $17.57M | $3.36M | 422.9 % |
Sep 2023 | 2023-11-06 | $9.28M | $1.57M | 491.2 % |
Aclaris Therapeutics (ACRS) is scheduled to report earnings on November 4, 2024. The last reported earnings were for reported on August 7, 2024 for Q2.
The Actual EPS was $-0.15, which beat the estimate of $-0.20.
The Actual Revenue was $2.8M, which beat the estimate of $1.8M.
Browse earnings estimates, EPS, and revenue on all stocks.